Recursion: Transforming Drug Discovery With Its AI-Powered Drug Development Platform
RXRXRecursion(RXRX) Seeking Alpha·2024-12-12 19:07

Recursion Pharmaceuticals (NASDAQ: RXRX ) is a technology-powered biopharmaceutical company, which is harnessing the power of artificial intelligence and machine learning to identify novel therapeutic targets for conditions with unmet clinical needs, accelerate drug discovery and reduceOriginally a Biologist, M.Sc in Biomedicine, PhD in Bioengineerings, and +20 years experience in the research and development of novel Cell & Gene Therapies (CGT) tackling several clinical needs including orthopaedics and rar ...